Insights on Life Sciences
Article
Closing the women’s health gap: Biopharma’s untapped opportunity
-
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.
Podcast
J&J’s Ashita Batavia on advancing oncology clinical-trials with data
-
Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine, discusses...
Article
Simplification for success: Rewiring the biopharma operating model
-
To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work,...
Podcast
GSK’s Kim Branson on driving innovation with AI and machine learning
-
Pharmaceutical giant GSK’s global head of AI and machine learning describes how these emerging technologies are reshaping...
Article
The transformation imperative: Igniting value creation in medtech
-
Leading medtech companies are embarking on bold transformations and evolving their operating models to unlock sustainable growth...
Special collection
RewiR&D: Making more medicines that matter
A selection of recently published articles that offer practical solutions to biopharmaceutical innovation challenges. Together, these articles provide a recipe to boost R&D productivity and accelerate the development of lifesaving therapies.
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.